• Listed Companies
  • Announcements
  • TIANJIN DEV
  • EN
  • 繁
  • 简
  • Aug 25, 2023
    06:12

    Potential Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd.

    Inside Information

    00882 - TIANJIN DEV


  • Aug 25, 2023
    06:10

    Unaudited Financial Results for the six months ended 30 June 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.

    Results of a Subsidiary

    00882 - TIANJIN DEV


  • Aug 18, 2023
    12:07

    Date of Board Meeting

    Date of Board Meeting

    00882 - TIANJIN DEV


  • Aug 10, 2023
    17:10

    Discloseable Transacttion - Resumption of the Properties held by Tianjin Lisheng Pharmaceutical Co., Ltd.

    Discloseable Transaction

    00882 - TIANJIN DEV


  • Aug 10, 2023
    16:36

    An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

    Overseas Regulatory Announcement - Other

    00882 - TIANJIN DEV


  • Aug 03, 2023
    16:44

    An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

    Overseas Regulatory Announcement - Other

    00882 - TIANJIN DEV


  • Aug 01, 2023
    17:30

    Connected Transaction - Subscription of Wealth Management Product

    Connected Transaction

    00882 - TIANJIN DEV


  • Jul 26, 2023
    06:13

    Potential Discloseable Transaction - Resumption of the Properties held by Tianjin Lisheng Pharmaceutical Co., Ltd.

    Inside Information

    00882 - TIANJIN DEV


  • ‹
  • 1
  • 2
  • ...
  • 11
  • 12
  • 13
  • ...
  • 59
  • 60
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2026 All right reserved.